These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38698963)

  • 1. Studying Signaling Pathway Activation in TRAIL-Resistant Macrophage-Like Acute Myeloid Leukemia Cells.
    Lomovskaya YV; Krasnov KS; Kobyakova MI; Kolotova AA; Ermakov AM; Senotov AS; Fadeeva IS; Fetisova EI; Lomovsky AI; Zvyagina AI; Akatov VS; Fadeev RS
    Acta Naturae; 2024; 16(1):48-58. PubMed ID: 38698963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage-like THP-1 Cells Derived from High-Density Cell Culture Are Resistant to TRAIL-Induced Cell Death via Down-Regulation of Death-Receptors DR4 and DR5.
    Lomovskaya YV; Kobyakova MI; Senotov AS; Lomovsky AI; Minaychev VV; Fadeeva IS; Shtatnova DY; Krasnov KS; Zvyagina AI; Akatov VS; Fadeev RS
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-Inflammatory Activation Suppresses TRAIL-induced Apoptosis of Acute Myeloid Leukemia Cells.
    Kobyakova MI; Senotov AS; Krasnov KS; Lomovskaya YV; Odinokova IV; Kolotova AA; Ermakov AM; Zvyagina AI; Fadeeva IS; Fetisova EI; Akatov VS; Fadeev RS
    Biochemistry (Mosc); 2024 Mar; 89(3):431-440. PubMed ID: 38648763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Increase in the Drug Resistance of Acute Myeloid Leukemia THP-1 Cells in High-Density Cell Culture Is Associated with Inflammatory-like Activation and Anti-Apoptotic Bcl-2 Proteins.
    Kobyakova M; Lomovskaya Y; Senotov A; Lomovsky A; Minaychev V; Fadeeva I; Shtatnova D; Krasnov K; Zvyagina A; Odinokova I; Akatov V; Fadeev R
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cells.
    Tazzari PL; Tabellini G; Ricci F; Papa V; Bortul R; Chiarini F; Evangelisti C; Martinelli G; Bontadini A; Cocco L; McCubrey JA; Martelli AM
    Cancer Res; 2008 Nov; 68(22):9394-403. PubMed ID: 19010914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.
    Riccioni R; Pasquini L; Mariani G; Saulle E; Rossini A; Diverio D; Pelosi E; Vitale A; Chierichini A; Cedrone M; Foà R; Lo Coco F; Peschle C; Testa U
    Haematologica; 2005 May; 90(5):612-24. PubMed ID: 15921376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAIL expression by activated human CD4(+)V alpha 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells.
    Nieda M; Nicol A; Koezuka Y; Kikuchi A; Lapteva N; Tanaka Y; Tokunaga K; Suzuki K; Kayagaki N; Yagita H; Hirai H; Juji T
    Blood; 2001 Apr; 97(7):2067-74. PubMed ID: 11264173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content.
    Gunalp S; Helvaci DG; Oner A; Bursalı A; Conforte A; Güner H; Karakülah G; Szegezdi E; Sag D
    Front Immunol; 2023; 14():1209249. PubMed ID: 37809073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicarpin, a legume phytoalexin sensitizes myeloid leukemia cells to TRAIL-induced apoptosis through the induction of DR5 and activation of the ROS-JNK-CHOP pathway.
    Trivedi R; Maurya R; Mishra DP
    Cell Death Dis; 2014 Oct; 5(10):e1465. PubMed ID: 25321472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcription factor Wilms tumor 1 confers resistance in myeloid leukemia cells against the proapoptotic therapeutic agent TRAIL (tumor necrosis factor α-related apoptosis-inducing ligand) by regulating the antiapoptotic protein Bcl-xL.
    Bansal H; Seifert T; Bachier C; Rao M; Tomlinson G; Iyer SP; Bansal S
    J Biol Chem; 2012 Sep; 287(39):32875-80. PubMed ID: 22898820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity.
    Wuchter C; Krappmann D; Cai Z; Ruppert V; Scheidereit C; Dörken B; Ludwig WD; Karawajew L
    Leukemia; 2001 Jun; 15(6):921-8. PubMed ID: 11417478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the Immune Escape Mechanism of Acute Myeloid Leukemia With DNMT3A Mutation.
    Que Y; Li H; Lin L; Zhu X; Xiao M; Wang Y; Zhu L; Li D
    Front Immunol; 2021; 12():653030. PubMed ID: 34093541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling through C/EBP homologous protein and death receptor 5 and calpain activation differentially regulate THP-1 cell maturation-dependent apoptosis induced by Shiga toxin type 1.
    Lee MS; Cherla RP; Lentz EK; Leyva-Illades D; Tesh VL
    Infect Immun; 2010 Aug; 78(8):3378-91. PubMed ID: 20515924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2.
    Chamuleau ME; Ossenkoppele GJ; van Rhenen A; van Dreunen L; Jirka SM; Zevenbergen A; Schuurhuis GJ; van de Loosdrecht AA
    Leuk Res; 2011 Jun; 35(6):741-9. PubMed ID: 21281967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro differentiation of myeloid suppressor cells (MDSC-like) from an immature myelomonocytic precursor THP-1.
    Varela VA; da Silva Heinen LB; Marti LC; Caraciolo VB; Datoguia TS; Amano MT; Pereira WO
    J Immunol Methods; 2023 Apr; 515():113441. PubMed ID: 36848984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells.
    Secchiero P; Zerbinati C; di Iasio MG; Melloni E; Tiribelli M; Grill V; Zauli G
    Curr Drug Metab; 2007 May; 8(4):395-403. PubMed ID: 17504227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathway.
    Premkumar DR; Jane EP; Foster KA; Pollack IF
    J Pharmacol Exp Ther; 2013 Aug; 346(2):201-10. PubMed ID: 23740602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR4/NF-κB axis induces fludarabine resistance by suppressing TXNIP expression in acute myeloid leukemia cells.
    Huy H; Kim TD; Kim WS; Kim DO; Byun JE; Kim MJ; Park YJ; Yoon SR; Noh JY; Lee J; Lee KH; Choi I; Jung H
    Biochem Biophys Res Commun; 2018 Nov; 506(1):33-40. PubMed ID: 30336978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor‑related apoptosis‑inducing ligand is a novel transcriptional target of runt‑related transcription factor 1.
    Yoshida T; Yamasaki K; Tadagaki K; Kuwahara Y; Matsumoto A; Sofovic AE; Kondo N; Sakai T; Okuda T
    Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34958111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation.
    Ho JNHG; Schmidt D; Lowinus T; Ryoo J; Dopfer EP; Gonzalo Núñez N; Costa-Pereira S; Toffalori C; Punta M; Fetsch V; Wertheimer T; Rittmann MC; Braun LM; Follo M; Briere C; Vinnakota JM; Langenbach M; Koppers F; Shoumariyeh K; Engel H; Rückert T; Märklin M; Holzmayer S; Illert AL; Magon F; Andrieux G; Duquesne S; Pfeifer D; Staniek J; Rizzi M; Miething C; Köhler N; Duyster J; Menssen HD; Boerries M; Buescher JM; Cabezas-Wallscheid N; Blazar BR; Apostolova P; Vago L; Pearce EL; Becher B; Zeiser R
    Blood; 2022 Sep; 140(10):1167-1181. PubMed ID: 35853161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.